Unidade de Investigación en Cardioloxía Celular e Molecular
C.C.M.
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von GlaxoSmithKline (United Kingdom) (1)
2018
-
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
The Lancet, Vol. 392, Núm. 10157, pp. 1519-1529